Intra Cellular Therapies | Driftsomkostninger



Operating Expenses Lave om Dato
Acadia Pharmaceuticals USD 106.1M 112.66M 2024-12
ALKERMES USD 267.3M 6.09M 2024-12
Biogen USD 2.01B 13.3M 2024-12
Bristol-Myers Squibb USD 11.55B 1.84B 2024-12
Cytokinetics USD 155.97M 14.7M 2024-12
Gilead Sciences USD 5.12B 1.54B 2024-12
Halozyme Therapeutics USD 122.51M 4.38M 2024-12
Intra Cellular Therapies USD 228.42M 14.2M 2024-12
J&J USD 18.63B 500M 2024-12
Neurocrine Biosciences USD 485.7M 47.4M 2024-12
Novartis USD 10.15B 579M 2024-12
Prothena USD 67.02M 463K 2024-12
RedHill Biopharma USD 5.51M 1.08M 2024-06
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12
United Therapeutics USD 378.2M 27.6M 2024-12



Intra Cellular Therapies Driftsomkostninger - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.